• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小唾液腺肿瘤的治疗结果——一家三级医疗中心20多年的经验

Outcomes in Minor Salivary Gland Tumors-A 20+ Year Tertiary-Care Center Experience.

作者信息

Zhang Emily S, Doty Samuel, Woody Neil, Bottalico Danielle, Ku Jamie A, Prendes Brandon, Koyfman Shlomo A, Campbell Shauna R, Silver Natalie, Scharpf Joseph, Lamarre Eric D

机构信息

Cleveland Clinic Head and Neck Institute Cleveland USA.

Case Western Reserve University School of Medicine Cleveland USA.

出版信息

OTO Open. 2024 Oct 8;8(4):e70030. doi: 10.1002/oto2.70030. eCollection 2024 Oct-Dec.

DOI:10.1002/oto2.70030
PMID:39381798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459202/
Abstract

OBJECTIVE

Minor salivary gland carcinomas are challenging to study due to their rarity and heterogeneity. We aim to further characterize clinical characteristics, treatment, and outcomes over 20 years within a single institution.

STUDY DESIGN

Retrospective chart review was conducted on 210 patients who received primary treatment for minor salivary gland malignancy from 2000 to 2022.

SETTING

Single tertiary-care center.

METHODS

Multivariable Cox proportional hazards method was used to examine the relationship between pre-determined clinically important variables and outcomes.

RESULTS

Five-year overall survival was 77.8% (72.0-84.1). Advanced clinical T stage portended over a 2 times higher risk of death and recurrence. High pathologic grade was associated with a near 3 times higher risk of death and recurrence. There was a predominance of occult nodal metastases in level II for oral cavity and oropharynx site tumors.

CONCLUSION

Clinical T stage and grade were important for overall survival, local, regional, and distant recurrence-free survival. Occult nodal metastases occurred most often in level II.

摘要

目的

小涎腺癌因其罕见性和异质性,研究颇具挑战性。我们旨在进一步描述单一机构内20年间的临床特征、治疗及预后情况。

研究设计

对2000年至2022年期间接受小涎腺恶性肿瘤初始治疗的210例患者进行回顾性病历审查。

研究地点

单一三级医疗中心。

方法

采用多变量Cox比例风险法来检验预先确定的具有临床重要性的变量与预后之间的关系。

结果

五年总生存率为77.8%(72.0 - 84.1)。临床T分期较晚预示死亡和复发风险高出2倍以上。高病理分级与死亡和复发风险高出近3倍相关。口腔和口咽部位肿瘤在Ⅱ区隐匿性淋巴结转移占主导。

结论

临床T分期和分级对总生存率、局部、区域和远处无复发生存率很重要。隐匿性淋巴结转移最常发生在Ⅱ区。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/11459202/2854398d764b/OTO2-8-e70030-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/11459202/929d183fb92a/OTO2-8-e70030-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/11459202/339e4dab848a/OTO2-8-e70030-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/11459202/2854398d764b/OTO2-8-e70030-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/11459202/929d183fb92a/OTO2-8-e70030-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/11459202/339e4dab848a/OTO2-8-e70030-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5c5/11459202/2854398d764b/OTO2-8-e70030-g001.jpg

相似文献

1
Outcomes in Minor Salivary Gland Tumors-A 20+ Year Tertiary-Care Center Experience.小唾液腺肿瘤的治疗结果——一家三级医疗中心20多年的经验
OTO Open. 2024 Oct 8;8(4):e70030. doi: 10.1002/oto2.70030. eCollection 2024 Oct-Dec.
2
Occult Nodal Metastases in Individuals with Clinically Node-Negative Salivary Gland Malignancies.临床淋巴结阴性涎腺癌患者隐匿性淋巴结转移。
Laryngoscope. 2024 Apr;134(4):1705-1715. doi: 10.1002/lary.31119. Epub 2023 Oct 17.
3
Management of nasopharyngeal salivary gland malignancy.鼻咽部涎腺恶性肿瘤的管理
Laryngoscope. 2001 Sep;111(9):1533-44. doi: 10.1097/00005537-200109000-00009.
4
Prognostic factors for development of distant metastases in surgically treated high-grade salivary gland carcinomas: results of retrospective single center study with 213 patients.手术治疗高级别涎腺癌远处转移的预后因素:回顾性单中心研究 213 例患者的结果。
Eur Arch Otorhinolaryngol. 2024 Sep;281(9):4947-4962. doi: 10.1007/s00405-024-08711-z. Epub 2024 May 6.
5
Minor salivary gland tumors of the head and neck-Memorial Sloan Kettering experience: Incidence and outcomes by site and histological type.头颈部小唾液腺肿瘤-纪念斯隆凯特琳经验:部位和组织学类型的发生率和结果。
Cancer. 2019 Oct 1;125(19):3354-3366. doi: 10.1002/cncr.32208. Epub 2019 Jun 7.
6
Characteristics, management of the neck, and oncological outcomes of malignant minor salivary gland tumours in the oral and sinonasal regions.口腔及鼻窦区域恶性小唾液腺肿瘤的特征、颈部处理及肿瘤学转归
Br J Oral Maxillofac Surg. 2013 Oct;51(7):e142-7. doi: 10.1016/j.bjoms.2012.05.004. Epub 2012 Aug 28.
7
Predictive factors for survival and treatment outcomes of patients with minor salivary gland malignancies: a retrospective study.小唾液腺癌患者生存和治疗结果的预测因素:一项回顾性研究。
Eur Arch Otorhinolaryngol. 2023 May;280(5):2561-2574. doi: 10.1007/s00405-023-07862-9. Epub 2023 Feb 12.
8
Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database.口腔和口咽黏液表皮样癌的预后因素和隐匿性淋巴结疾病:国家癌症数据库分析。
Oral Oncol. 2017 Sep;72:174-178. doi: 10.1016/j.oraloncology.2017.07.025. Epub 2017 Jul 27.
9
The Number of Positive Lymph Nodes Instead of Extranodal Extension and Nodal Diameter is an Independent Predictor of Survival and Treatment Outcome of High-Grade Parotid Gland Carcinoma.阳性淋巴结数量而非结外侵犯和淋巴结直径是高级腮腺腺癌生存和治疗结果的独立预测因子。
J Oral Maxillofac Surg. 2024 Nov;82(11):1456-1474. doi: 10.1016/j.joms.2024.06.179. Epub 2024 Jun 29.
10
Pathological nodal status as a main predictive factor of survival and treatment outcomes of submandibular salivary gland cancers: A 25-year single center experience.下颌下唾液腺癌生存和治疗结果的主要预测因素:25 年单中心经验。
J Stomatol Oral Maxillofac Surg. 2023 Dec;124(6):101462. doi: 10.1016/j.jormas.2023.101462. Epub 2023 Mar 30.

本文引用的文献

1
Minor Salivary Gland Cancer of the Head and Neck: A Review of Epidemiologic Aspects, Prognostic Factors, and Outcomes.头颈部小唾液腺癌:流行病学、预后因素及结局综述
Curr Oncol Rep. 2023 Mar;25(3):173-179. doi: 10.1007/s11912-022-01356-3. Epub 2023 Jan 27.
2
Occult Neck Metastases in Head and Neck Adenoid Cystic Carcinoma: A Systematic Review and Meta-Analysis.头颈部腺样囊性癌的隐匿性颈部转移:一项系统评价和荟萃分析
J Clin Med. 2022 Aug 22;11(16):4924. doi: 10.3390/jcm11164924.
3
Prediction of Minor Salivary Gland Carcinoma: A Novel Nomogram and Risk Classification System for Overall Survival and Cancer-Specific Survival.
预测小唾液腺癌:一种用于总生存和癌症特异性生存的新的列线图和风险分类系统。
Otolaryngol Head Neck Surg. 2021 Feb;164(2):359-368. doi: 10.1177/0194599820938323. Epub 2020 Jul 21.
4
The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan.临床病理因素对涎腺腺样囊性癌患者临床结局的影响:日本多机构分析。
Int J Clin Oncol. 2020 Oct;25(10):1774-1785. doi: 10.1007/s10147-020-01731-9. Epub 2020 Jul 1.
5
Primary Epithelial Minor Salivary Gland Tumors in South Africa: A 20-Year Review.南非原发性上皮性小唾液腺肿瘤:20 年回顾。
Head Neck Pathol. 2020 Sep;14(3):715-723. doi: 10.1007/s12105-019-01111-4. Epub 2019 Dec 23.
6
Elective neck dissection in adenoid cystic carcinoma of head and neck: yes or no? A systematic review.头颈部腺样囊性癌选择性颈清扫术:应或不应?一项系统评价。
Eur Arch Otorhinolaryngol. 2019 Nov;276(11):2957-2962. doi: 10.1007/s00405-019-05669-1. Epub 2019 Oct 3.
7
Minor salivary gland tumors of the head and neck-Memorial Sloan Kettering experience: Incidence and outcomes by site and histological type.头颈部小唾液腺肿瘤-纪念斯隆凯特琳经验:部位和组织学类型的发生率和结果。
Cancer. 2019 Oct 1;125(19):3354-3366. doi: 10.1002/cncr.32208. Epub 2019 Jun 7.
8
Survival in patients with submandibular gland carcinoma - Results of a multi-institutional retrospective study.下颌下腺癌患者的生存情况——一项多机构回顾性研究的结果
Auris Nasus Larynx. 2018 Oct;45(5):1066-1072. doi: 10.1016/j.anl.2018.01.011. Epub 2018 Feb 7.
9
Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database.口腔和口咽黏液表皮样癌的预后因素和隐匿性淋巴结疾病:国家癌症数据库分析。
Oral Oncol. 2017 Sep;72:174-178. doi: 10.1016/j.oraloncology.2017.07.025. Epub 2017 Jul 27.
10
Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review.口腔和口咽腺样囊性癌的颈部淋巴结转移:一项国际综合综述。
Auris Nasus Larynx. 2016 Oct;43(5):477-84. doi: 10.1016/j.anl.2016.02.013. Epub 2016 Mar 24.